Publication | Open Access
miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4.
54
Citations
25
References
2015
Year
Our finding provides new insight into the mechanism of NSCLC progression. Therapeutically, miR-132 may serve as a potential target in the treatment of human lung cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1